Stocktoria
GoodRx Holdings, Inc. GDRX
Nasdaq · XNAS · stock · Services-Computer Processing & Data Preparation · website · IPO 2020-09-23
GoodRx Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $796.9M | $792.3M | $750.3M | $766.6M | $745.4M |
| R&D expense | $121.0M | $123.7M | $135.8M | $143.1M | $125.9M |
| Operating income | $87.5M | $65.8M | -$27.0M | $1.7M | $13.4M |
| Income tax | $26.1M | $15.1M | -$46.7M | $9.6M | $15.1M |
| Net income | $30.4M | $16.4M | -$8.9M | -$32.8M | -$25.3M |
| EPS (diluted) | $0.09 | $0.04 | $-0.02 | $-0.08 | $-0.06 |
| Operating cash flow | $167.9M | $183.9M | $138.3M | $146.8M | $178.8M |
| Free cash flow | $164.4M | $182.7M | $137.2M | $142.8M | $174.2M |
| Cash & equivalents | $261.8M | $448.3M | $672.3M | $757.2M | $941.1M |
| Total assets | $1.4B | $1.4B | $1.6B | $1.6B | $1.6B |
| Total liabilities | $787.8M | $663.4M | $826.8M | $789.8M | $775.9M |
| Shareholders' equity | $616.3M | $724.7M | $762.0M | $814.8M | $831.7M |
Source: SEC EDGAR filings · CIK 0001809519 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.